NEXT

The Legal Intelligencer

In re Zoloft Products Liability Litigation, PICS Case No. 17-1111 (E.D. Pa. June 20, 2017) Rufe, J. (8 pages).

Court denied plaintiffs' motion to remand for lack of diversity in action alleging fraudulent concealment and failure to warn in drug birth defect case because the court found that the undiverse defendant was fraudulently joined since plaintiffs lacked a good-faith intent to prosecute their claims against that defendant. Motion denied.
3 minute read

The Legal Intelligencer

Phila. Case Over Asbestos-Infused Talc Could Set Pattern for Series of Claims

The high-profile litigation in Missouri over talcum powder might be beginning to cool down, thanks to a recent U.S. Supreme Court decision, but a talc-related litigation in Pennsylvania is beginning to heat up, and may set a pattern for a growing area for tort claims.
5 minute read

Corporate Counsel

Former 'FDA Generalist' at Pfizer Joins Venable

A former top lawyer at Pfizer Inc. has returned to private practice at Venable after about nine years in-house.
7 minute read

The American Lawyer

Fish & Richardson Set to Receive $12.5M Fee Award in Gilead-Merck Infringement Battle

Fish & Richardson and client Gilead Sciences Inc. are slated to receive nearly $14 million in legal fees after exposing patent misconduct by Merck & Co. Inc. that helped Gilead shake off a $200 million infringement verdict.
3 minute read

Corporate Counsel

FDA Policy Vet Joins Generic Drug Advocacy Group

Rachel Sher is joining the Association for Accessible Medicines as deputy general counsel.
3 minute read

The Legal Intelligencer

Fox Rothschild Pharma Practice Chief Leaves for In-House Post

Generic pharmaceutical manufacturer Lannett Co. Inc. has appointed its longtime outside lawyer to serve as chief legal officer and general counsel.
11 minute read

National Law Journal

Eleventh-Hour Settlement in Cialis Patent Suit Clears Path for Generics

Generic drug makers, including Teva, had been set to go to trial Monday against Eli Lilly &amp Co. The deal ends Lilly's exclusivity over Cialis in 2018.
10 minute read

The Legal Intelligencer

Phila. Risperdal Docket More Than Doubles in First Half of 2017

The litigation over Risperdal has not only become the largest mass tort program in Philadelphia's busy court system, it has also nearly tripled in size from about 2,000 cases at the start of the year to more than 5,500 as of June.
5 minute read

National Law Journal

Former FDA Official: Stronger Deterrence of Food-Borne Outbreaks, Increased Cooperation on Tap for the Agency

Howard Sklamberg, former deputy commissioner for global regulatory operations and policy at the FDA, says it's an "interesting time" for the agency.
13 minute read

Litigation Daily

When Lawyers are CEOs, Good Things Happen (Most of the Time)

Move over philosopher-kings—let's hear it for the lawyer-CEOs. A new study of publicly traded companies headed by chief executives who also have law degrees found that such companies don't get sued as often, and when they do, the consequences of litigation are less severe.
12 minute read

Resources

  • Why Embracing Change Is Essential for Your Legal Department

    Brought to you by DiliTrust

    Download Now

  • International Export and Trade Assistance State Law Survey

    Brought to you by LexisNexis®

    Download Now

  • How This Personal Injury Firm Reduced Client Intake Time by 80%

    Brought to you by PracticePanther

    Download Now

  • The Hidden Cost of Bad Reviews: Why Law Firms & Attorneys Can't Afford a Damaged Online Reputation

    Brought to you by Erase.com

    Download Now